ATE480625T1 - Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion - Google Patents

Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion

Info

Publication number
ATE480625T1
ATE480625T1 AT07101045T AT07101045T ATE480625T1 AT E480625 T1 ATE480625 T1 AT E480625T1 AT 07101045 T AT07101045 T AT 07101045T AT 07101045 T AT07101045 T AT 07101045T AT E480625 T1 ATE480625 T1 AT E480625T1
Authority
AT
Austria
Prior art keywords
chlamydia pneumoniae
polypeptides
infection
prevention
relates
Prior art date
Application number
AT07101045T
Other languages
English (en)
Inventor
Remy Griffais
Susan K Hoiseth
Robert John Zagursky
Benjamin J Metcalf
Joel A Peek
Banumathi Sankaran
Leah Diane Fletcher
Original Assignee
Merck Serono Biodevelopment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Biodevelopment filed Critical Merck Serono Biodevelopment
Application granted granted Critical
Publication of ATE480625T1 publication Critical patent/ATE480625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07101045T 1997-11-21 1998-11-20 Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion ATE480625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714673 1997-11-21
US10707898P 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
ATE480625T1 true ATE480625T1 (de) 2010-09-15

Family

ID=9513667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07101045T ATE480625T1 (de) 1997-11-21 1998-11-20 Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion

Country Status (6)

Country Link
US (4) US6559294B1 (de)
AT (1) ATE480625T1 (de)
CY (1) CY1106408T1 (de)
DE (1) DE69841894D1 (de)
ES (1) ES2352082T3 (de)
PT (1) PT1032674E (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
US20020094340A1 (en) * 1998-12-01 2002-07-18 Andrew D. Murdin Chlamydia antigens and corresponding dna thereof
ATE318924T1 (de) * 1998-12-04 2006-03-15 Univ Manitoba Zwei-schritte-verfahren zur impfung gegen chlamydia
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US7297341B1 (en) * 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2003512017A (ja) 1998-12-23 2003-04-02 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US6808713B1 (en) * 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1163342B1 (de) * 1999-03-12 2008-12-10 Aventis Pasteur Limited Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
US20030095973A1 (en) * 1999-05-03 2003-05-22 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CN100406469C (zh) * 1999-09-21 2008-07-30 日本烟草产业株式会社 新蛋白质,其编码基因及它们的使用方法
WO2001036455A2 (en) * 1999-11-12 2001-05-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046224A2 (en) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20020071831A1 (en) * 2000-04-04 2002-06-13 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en) * 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20040254130A1 (en) * 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001274931B2 (en) * 2000-05-23 2006-03-30 Nexell Therapeutics, Inc. Reagents for cell selection and methods of use
CA2414884A1 (en) * 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae
US7811592B2 (en) * 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
DE60142693D1 (de) * 2000-09-08 2010-09-09 Daiichi Sankyo Co Ltd Arzneimittel für herzversagen
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US20040131624A1 (en) * 2000-12-14 2004-07-08 Agathe Subtil Secreted chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type lll secretion pathway of a gram-negative bacteria.
US20070149474A1 (en) * 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US8206724B2 (en) * 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
IL158293A0 (en) * 2001-04-10 2004-05-12 Agensys Inc Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
US20080112965A1 (en) * 2001-10-01 2008-05-15 Aventis Pasteur Limited Chlamydia OMP antigen
AU2003217355B2 (en) * 2002-02-07 2009-04-23 University Of Utah Research Foundation Method for creating and using a treatment protocol
US8257967B2 (en) * 2002-04-26 2012-09-04 Board Of Regents, The University Of Texas System Method and system for the detection of cardiac risk factors
WO2004047759A2 (en) * 2002-11-22 2004-06-10 Wyeth Composition for treating chlamydia infections and method for identifying same
CA2516971A1 (en) * 2003-02-24 2004-09-02 Institut Pasteur Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
US20060240029A1 (en) * 2003-06-17 2006-10-26 Intercell Ag Chlamydia pneumoniae antigens
US20050042214A1 (en) * 2003-07-15 2005-02-24 Gershwin M. Eric Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
MXPA06012987A (es) * 2004-05-11 2007-06-12 Abgenomics Corp Epitopos inductores de muerte de celulas t.
WO2006086019A2 (en) * 2004-10-21 2006-08-17 Optiscan Biomedical Corporation Methods of treating diabetes
US20060177859A1 (en) * 2005-02-07 2006-08-10 Gen-Probe Incorporated Compositions and methods for detecting group B streptococci
WO2007053186A2 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
CA2609206A1 (en) * 2005-06-06 2006-12-14 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
EP1905825A1 (de) * 2006-09-29 2008-04-02 greenovation Biotech GmbH Galactosyltransferase
US20080160027A1 (en) * 2006-12-04 2008-07-03 Kathryn Frances Sykes Chlamydia pneumoniae vaccine and methods for administering such a vaccine
US20090092969A1 (en) * 2007-10-09 2009-04-09 Michael Aye Detection of atypical pneumonia
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
CN102822352B (zh) * 2010-03-31 2015-07-29 有限会社山口技术特许机构 利用核酸色谱法的肺炎病原菌的检出方法
KR101311886B1 (ko) 2010-05-26 2013-09-26 한국기초과학지원연구원 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물
CN104725507B (zh) * 2010-10-19 2018-12-21 梅奥医学教育和研究基金会 用于治疗神经疾病的人抗体及其诊断和治疗用途
CA2858350A1 (en) 2011-01-14 2013-07-19 The Regents Of The University Of California Therapeutic antibodies against ror-1 protein and methods for use of same
US9944677B2 (en) 2013-03-15 2018-04-17 Georgetown University Selective inhibitor of angiotensin II
US10835594B2 (en) 2014-01-16 2020-11-17 Mcmaster University Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
CN114137209B (zh) * 2021-02-01 2024-03-01 中国水产科学研究院黄海水产研究所 一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6493591B1 (en) * 2000-07-19 2002-12-10 Medtronic, Inc. Implantable active fixation lead with guidewire tip

Also Published As

Publication number Publication date
US7601531B2 (en) 2009-10-13
US7101963B2 (en) 2006-09-05
US20040006218A1 (en) 2004-01-08
PT1032674E (pt) 2007-03-30
US6559294B1 (en) 2003-05-06
US20090274701A1 (en) 2009-11-05
US20070053927A1 (en) 2007-03-08
ES2352082T3 (es) 2011-02-15
DE69841894D1 (de) 2010-10-21
CY1106408T1 (el) 2011-10-12

Similar Documents

Publication Publication Date Title
DE69841894D1 (de) Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
DK1032674T3 (da) Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion
WO1999028475A3 (en) Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Sedgley et al. Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp.
DE3588239T3 (de) Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
WO2003008611A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced talb gene
WO2003004675A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
WO2003008602A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene
Wescombe et al. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius
RU2673733C2 (ru) Способ амплификации днк на основе внедрения в цепь
WO2002036797A3 (en) Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family
DE69534747D1 (de) Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure
EP1214450B1 (de) Verfahren und nukleinsäuren zum nachweis von brauereirelevanten mikroorganismen
WO2002024904A2 (de) Verfahren zur herstellung von ribonukleinsäure (rns)
AU2002342763A1 (en) Process for the preparation of non-aromatic l-amino acids using strains of the enterobacteriaceae family
Ikehara Possible Application of Entirely New Gene/Protein to Clinical Research
JP2008092948A (ja) 検体中の標的核酸を検出するためのキットおよび方法
ATE321862T1 (de) Coryneforme bakterien transformiert mit dem pknd- gen kodierenden nukleotidsequenzen und deren verwendung zur herstellung von l -aminosäuren
WO2003076629A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
MCKEE Primers are used at 20 pmol final concentration Target DNA is not generally isolated, cells are added to the reaction with or without a boiling (5 min) step
WO2001051655A2 (de) Oligonukleotide zur amplifikation und zum nachweis von bakteriellen genen für extrazelluläre alkalische metallopeptidasen (apr), neutrale metallopeptidasen (npr) und serinpeptidasen (spr)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties